07:52 AM EST, 01/28/2026 (MT Newswires) -- Novo Nordisk ( NVO ) spent roughly $500 million on US advertising for its Wegovy and Ozempic medications in the first nine months of 2025, over double what Eli Lilly ( LLY ) spent for its rival drugs, Reuters reported Wednesday, citing data from MediaRadar.

Novo Nordisk ( NVO ) and Eli Lilly ( LLY ) didn't immediately reply to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)